Laura Brambilla

Fondazione IRCCS Istituto Neurologico "C. Besta"

Emaillaura.brambilla@istituto-besta.it

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Laura Brambilla is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

7 Article

Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups
Donninelli, G., Studer, V., Brambilla, L., Zecca, C., Peluso, D., Laroni, A., Michelis, D., Mantegazza, R., Confalonieri, P. & Volpe, E., Mar 10 2021, In: Frontiers in Immunology. 12, 633167.
Research output: Contribution to journal › Article › peer-review

Open Access
Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups
Donninelli, G., Studer, V., Brambilla, L., Zecca, C., Peluso, D., Laroni, A., Michelis, D., Mantegazza, R., Confalonieri, P. & Volpe, E., 2021, In: Front. Immunol.. 12
Research output: Contribution to journal › Article › peer-review
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
iMUST group, Nov 1 2019, In: Multiple Sclerosis and Related Disorders. 36, 101430.
Research output: Contribution to journal › Article › peer-review
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Zecca, C., Bovis, F., Novi, G., Capobianco, M., Lanzillo, R., Frau, J., Repice, A. M., Hakiki, B., Realmuto, S., Bonavita, S., Curti, E., Brambilla, L., Mataluni, G., Cavalla, P., Di Sapio, A., Signoriello, E., Barone, S., Maniscalco, G. T., Maietta, I., Maraffi, I. & 25 others, Boffa, G., Malucchi, S., Nozzolillo, A., Coghe, G., Mechi, C., Salemi, G., Gallo, A., Sacco, R., Cellerino, M., Malentacchi, M., De Angelis, M., Lorefice, L., Magnani, E., Prestipino, E., Sperli, F., Brescia Morra, V., Fenu, G., Barilaro, A., Abbadessa, G., Signori, A., Granella, F., Amato, M. P., Uccelli, A., Gobbi, C. & Sormani, M. P., Oct 1 2019, In: Multiple Sclerosis. p. 1352458519872889
Research output: Contribution to journal › Article › peer-review
Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience
Zecca, C., Bovis, F., Novi, G., Capobianco, M., Lanzillo, R., Frau, J., Repice, A. M., Hakiki, B., Realmuto, S., Bonavita, S., Curti, E., Brambilla, L., Mataluni, G., Cavalla, P., Di Sapio, A., Signoriello, E., Barone, S., Maniscalco, G. T., Maietta, I., Maraffi, I. & 25 others, Boffa, G., Malucchi, S., Nozzolillo, A., Coghe, G., Mechi, C., Salemi, G., Gallo, A., Sacco, R., Cellerino, M., Malentacchi, M., De Angelis, M., Lorefice, L., Magnani, E., Prestipino, E., Sperli, F., Brescia Morra, V., Fenu, G., Barilaro, A., Abbadessa, G., Signori, A., Granella, F., Amato, M. P., Uccelli, A., Gobbi, C. & Sormani, M. P., Jan 1 2019, (Accepted/In press) In: Multiple Sclerosis Journal.
Research output: Contribution to journal › Article › peer-review

Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups

Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.

Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience